PatientsVille.com Logo

PatientsVille

Levora Side Effects

Common Levora Side Effects


The most commonly reported Levora side effects (click to view or check a box to report):

Pulmonary Embolism (4)
Dizziness (3)
Feeling Abnormal (3)
Cholelithiasis (3)
Hypothyroidism (2)
Joint Swelling (2)
Hypoaesthesia (2)
Confusional State (2)
Cytolytic Hepatitis (2)
Swollen Tongue (2)
Cholecystitis Acute (2)
Cholecystitis (2)
Pancreatitis (2)
Local Swelling (2)
Lip Swelling (2)
Menstruation Irregular (2)
Nausea (2)
Rash (2)
Pain (2)
Swelling Face (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Levora Side Effects Reported to FDA

The following Levora reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Levora on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Malaise, Nausea, Feeling Abnormal, Depression
This is a report of a 19-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: contraception, who was treated with Levora (dosage: 1 Pill, start time: Nov 01, 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Malaise
  • Nausea
  • Feeling Abnormal
  • Depression
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Levora treatment in female patients, resulting in malaise side effect.

Muscle Spasms, Middle Insomnia, Blood Potassium Decreased, Deep Vein Thrombosis, Pulmonary Embolism
This report suggests a potential Levora Muscle Spasms, Middle Insomnia, Blood Potassium Decreased, Deep Vein Thrombosis, Pulmonary Embolism side effect(s) that can have serious consequences. A 42-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: menorrhagia and used Levora (dosage: NA) starting Dec 23, 2012. Soon after starting Levora the patient began experiencing various side effects, including:
  • Muscle Spasms
  • Middle Insomnia
  • Blood Potassium Decreased
  • Deep Vein Thrombosis
  • Pulmonary Embolism
Drugs used concurrently: NA.The patient was hospitalized. Although Levora demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as muscle spasms, may still occur.

Swelling, Myocardial Infarction, Heart Injury, Hypoaesthesia
This Swelling, Myocardial Infarction, Heart Injury, Hypoaesthesia problem was reported by a consumer or non-health professional from UNITED STATES. A 41-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 01, 2000 this consumer started treatment with Levora 0.15/30-21 (dosage: NA). The following drugs were being taken at the same time:
  • Avandamet
  • Glucotrol Xl
  • Glucophage
  • Avandaryl
  • Avandia (8mg Per Day)
  • Lipitor
  • Zoloft
  • Hyzaar
When commencing Levora 0.15/30-21, the patient experienced the following unwanted symptoms/side effects:
  • Swelling
  • Myocardial Infarction
  • Heart Injury
  • Hypoaesthesia
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as swelling, may become evident only after a product is in use by the general population.

Pregnancy After Post Coital Contraception
This is a report of a female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: contraception,post coital contraception and was treated with Levora 0.15/30-21 (dosage: NA) starting May 06, 2012. Concurrently used drugs:
  • Plan B One-step (1.5 Milligram;)
Soon after that, the consumer experienced the following side effects:
  • Pregnancy After Post Coital Contraception
This opens a possibility that Levora 0.15/30-21 treatment could cause the above reactions, including pregnancy after post coital contraception, and some female subjects may be more susceptible.


Disturbance In Attention, Feeling Abnormal, Dry Mouth, Glossodynia, Swollen Tongue
A female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: NA started Levora 0.15/30-21 treatment (dosage: NA) on Jan 01, 2007. Soon after starting Levora 0.15/30-21 treatment, the subject experienced various side effects, including:
  • Disturbance In Attention
  • Feeling Abnormal
  • Dry Mouth
  • Glossodynia
  • Swollen Tongue
Concurrently used drugs:
  • Multi-vitamins
  • Cholest-off
  • Fluoxetine
  • Lysine
  • Nuvigil (250 Milligram;)
  • Calcium W/magnesium/vitamin D
This finding indicates that some female patients could be more vulnerable to Levora 0.15/30-21.

Depression, Crying, Asthenia
A female patient from UNITED STATES (weight: NA) experienced symptoms, such as: contraception,depression and was treated with Levora 0.15/30-21(dosage: 0.15/30, Unk). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Depression
  • Crying
  • Asthenia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Levora 0.15/30-21 efficacy:
  • Effexor Xr (225 Mg, 1x/day)


Pain, Gallbladder Disorder, Emotional Distress, Cholecystitis Acute, Pancreatitis
In this report, Levora 0.15/30-21 was administered for the following condition: NA.A 33-year-old female consumer from UNITED STATES (weight: NA) started Levora 0.15/30-21 treatment (dosage: NA) on Nov 01, 2007.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Pain
  • Gallbladder Disorder
  • Emotional Distress
  • Cholecystitis Acute
  • Pancreatitis
A possible interaction with other drugs could have contributed to this reaction:
  • Yaz (Unk)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Levora 0.15/30-21 treatment could be related to the listed above side effect(s).

Menstrual Disorder, Dysmenorrhoea
This is a report of the following Levora 0.15/30-21 side effect(s):
  • Menstrual Disorder
  • Dysmenorrhoea
A female patient from UNITED STATES (weight: NA) presented with the following condition: contraception,depression and received a treatment with Levora 0.15/30-21 (dosage: 0.15/0.03 Mg, Daily) starting: Jan 01, 2010.The following concurrently used drugs could have generated interactions:
  • Pristiq (Unk)
This report suggests that a Levora 0.15/30-21 treatment could be associated with the listed above side effect(s).

Lip Swelling, Acne, Syncope, Abdominal Pain Upper, Rash
This Levora 0.15/30-21 report was submitted by a 26-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: NA and Levora 0.15/30-21 was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Lip Swelling
  • Acne
  • Syncope
  • Abdominal Pain Upper
  • Rash
Other drugs used simultaneously:
  • Terbinafine Hcl (250 Mg)
The patient was hospitalized.Those unexpected symptoms could be linked to a Levora 0.15/30-21 treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Dizziness, Confusional State, Vision Blurred, Hypoaesthesia
This is a report of a possible correlation between Levora 0.15/30-21 use and the following symptoms/side effect(s):
  • Dizziness
  • Confusional State
  • Vision Blurred
  • Hypoaesthesia
which could contribute to an assessment of Levora 0.15/30-21 risk profile.A 37-year-old female consumer from UNITED STATES (weight: NA) was suffering from menstrual disorder,mood swings,contraception and was treated with Levora 0.15/30-21 (dosage: 1 Pill) starting Aug 05, 2011.Other concurrent medications: NA.The patient was hospitalized.

Cholelithiasis, Cholecystitis Acute, Gallbladder Disorder, Gallbladder Pain, Cholecystectomy
A 26-year-old female patient from UNITED STATES (weight: NA) presented with the following symptoms: NA and after a treatment with Levora 0.15/30-21 (dosage: Unk) experienced the following side effect(s):
  • Cholelithiasis
  • Cholecystitis Acute
  • Gallbladder Disorder
  • Gallbladder Pain
  • Cholecystectomy
The treatment was started on Sep 01, 2005. Levora 0.15/30-21 was used in combination with the following drugs:
  • Yasmin (Unk Unk, Qd)
  • Oral Contraceptive Nos
  • Drospirenone And Ethinyl Estradiol (Unk)
  • Yaz (Unk Unk, Qd)
  • Valtrex (Unk)
The patient was hospitalized.This report could alert potential Levora 0.15/30-21 consumers.

Colitis Ischaemic, Hypercoagulation
In this report, a female patient from UNITED STATES (weight: NA) was affected by a possible Levora Ethinyl Estradiol 0.03mg/ Levonorgestrol 0.15mg Watson Pharmace side effect.The patient was diagnosed with contraception. After a treatment with Levora Ethinyl Estradiol 0.03mg/ Levonorgestrol 0.15mg Watson Pharmace (dosage: 1 Tablet Daily Oral, start date: Mar 09, 2009), the patient experienced the following side effect(s):
  • Colitis Ischaemic
  • Hypercoagulation
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Levora Ethinyl Estradiol 0.03mg/ Levonorgestrol 0.15mg Watson Pharmace treatment.

Gallbladder Non-functioning, Cholecystitis
This is a report of a 18-year-old female patient from UNITED STATES (weight: NA), who used Levora 0.15/30-21 (dosage: Unk) for a treatment of NA. After starting a treatment on May 04, 2006, the patient experienced the following side effect(s):
  • Gallbladder Non-functioning
  • Cholecystitis
The following drugs could possibly have interacted with the Levora 0.15/30-21 treatment
  • Yasmin (Unk)
  • Yasmin
The patient was hospitalized.Taken together, these observations suggest that a Levora 0.15/30-21 treatment could be related to side effect(s), such as Gallbladder Non-functioning, Cholecystitis.

Cytolytic Hepatitis
This cytolytic hepatitis side effect was reported by a health professional from FRANCE. A 29-year-old female patient (weight:NA) experienced the following symptoms/conditions: oral contraception. The patient was prescribed Levora 0.15/30-21 (dosage: Unk), which was started on Jul 01, 2008. Concurrently used drugs: NA. When starting to take Levora 0.15/30-21 the consumer reported the following symptoms:
  • Cytolytic Hepatitis
The patient was hospitalized. These side effects may potentially be related to Levora 0.15/30-21.

Cytolytic Hepatitis
This is a Levora 0.15/30-21 side effect report of a 28-year-old female patient (weight:NA) from FRANCE, suffering from the following symptoms/conditions: oral contraception, who was treated with Levora 0.15/30-21 (dosage:Unk, start time: Jan 01, 2008), combined with: NA., and developed a serious reaction and a cytolytic hepatitis side effect. The patient presented with:
  • Cytolytic Hepatitis
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Levora 0.15/30-21 treatment in female patients suffering from oral contraception, resulting in cytolytic hepatitis.

No Adverse Event
This report suggests a potential Levora 0.15/30-21 no adverse event side effect(s) that can have serious consequences. A 23-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): contraception and used Levora 0.15/30-21 (dosage: Unk) starting Mar 30, 2011. Soon after starting Levora 0.15/30-21 the patient began experiencing various side effects, including:
  • No Adverse Event
Drugs used concurrently:
  • Aleve (caplet) (880 Mg, Once)
Although Levora 0.15/30-21 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as no adverse event, may still occur.

Cholelithiasis, Jaundice, Cholecystitis, Pain
This cholelithiasis problem was reported by a consumer or non-health professional from UNITED STATES. A female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Jan 01, 2008 a consumer started treatment with Levora 0.15/30-28 (dosage: Unk). The following drugs/medications were being taken at the same time:
  • Ibuprofen
  • Advil Liqui-gels
  • Uncodeable ^unclassifiable^
  • Uncodeable ^unclassifiable^
  • Yasmin (Unk)
  • Microgestin 1.5/30 (Unk)
When commencing Levora 0.15/30-28, the patient experienced the following unwanted symptoms /side effects:
  • Cholelithiasis
  • Jaundice
  • Cholecystitis
  • Pain
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as cholelithiasis, may become evident only after a product is in use by the general population.

Menstruation Irregular
This is a Levora 0.15/30-21 side effect report of a female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: contraception,post coital contraception and was treated with Levora 0.15/30-21 (dosage: NA) starting Mar 13, 2011. Concurrently used drugs:
  • Plan B One-step
Soon after that, the consumer experienced the following of symptoms:
  • Menstruation Irregular
This opens a possibility that Levora 0.15/30-21 could cause menstruation irregular and that some female patients may be more susceptible.

Menstruation Irregular
A female patient (weight: NA) from UNITED STATES with the following symptoms: contraception,post coital contraception started Levora 0.15/30-21 treatment (dosage: NA) on Mar 13, 2011. Soon after starting Levora 0.15/30-21 treatment, the consumer experienced several side effects, including:
  • Menstruation Irregular
. Concurrently used drugs:
  • Plan B One-step
This finding indicates that some patients can be more vulnerable to developing Levora 0.15/30-21 side effects, such as menstruation irregular.

Apnoea, Bradycardia, Hypotension
This apnoea side effect was reported by a physician from UNITED STATES. A 22-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Levora 0.15/30-28 (dosage: NA), which was started on Jan 26, 2011. Concurrently used drugs:
  • Versed
  • Fentanyl
  • Cymbalta
  • Ketamine Hcl
  • Contraceptives
.When starting to take Levora 0.15/30-28 the consumer reported symptoms, such as:
  • Apnoea
  • Bradycardia
  • Hypotension
These side effects may potentially be related to Levora 0.15/30-28.

Retinal Vein Occlusion, Cerebral Venous Thrombosis
This is a report of a 29-year-old female patient (weight: NA) from AUSTRALIA, suffering from the following symptoms/conditions: oral contraception, who was treated with Levora 0.15/30-21 (dosage: Unk, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Retinal Vein Occlusion
  • Cerebral Venous Thrombosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Levora 0.15/30-21 treatment in female patients, resulting in retinal vein occlusion side effect.

Cerebrovascular Accident, Coronary Artery Disease
This report suggests a potential Levora 0.15/30-21 Cerebrovascular Accident, Coronary Artery Disease side effect(s) that can have serious consequences. A 43-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Levora 0.15/30-21 (dosage: Once Daily By Mouth) starting Jun 01, 2009. Soon after starting Levora 0.15/30-21 the patient began experiencing various side effects, including:
  • Cerebrovascular Accident
  • Coronary Artery Disease
Drugs used concurrently:
  • Imitrex
The patient was hospitalized and became disabled. Although Levora 0.15/30-21 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cerebrovascular accident, may still occur.

Ectopic Pregnancy, Fallopian Tube Perforation, Menorrhagia
This Ectopic Pregnancy, Fallopian Tube Perforation, Menorrhagia problem was reported by a consumer or non-health professional from UNITED STATES. A 34-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: contraception. On Mar 01, 2010 this consumer started treatment with Levora 0.15/30-28 (watson Laboratories) (dosage: 1 Tablet, Daily). The following drugs were being taken at the same time: NA. When commencing Levora 0.15/30-28 (watson Laboratories), the patient experienced the following unwanted symptoms/side effects:
  • Ectopic Pregnancy
  • Fallopian Tube Perforation
  • Menorrhagia
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as ectopic pregnancy, may become evident only after a product is in use by the general population.

Abdominal Pain, Arthralgia, Dyspnoea, Joint Stiffness, Lip Swelling, Nausea, Swollen Tongue, Urticaria
This is a report of a 24-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Levora 0.15/30-21 (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Abdominal Pain
  • Arthralgia
  • Dyspnoea
  • Joint Stiffness
  • Lip Swelling
  • Nausea
  • Swollen Tongue
  • Urticaria
This opens a possibility that Levora 0.15/30-21 treatment could cause the above reactions, including abdominal pain, and some female subjects may be more susceptible.

Angiosarcoma, Hepatic Failure
A 43-year-old female patient (weight: NA) from INDIA with the following symptoms/conditions: menorrhagia started Levora 0.15/30-28 (watson Laboratories) treatment (dosage: Unk) on NS. Soon after starting Levora 0.15/30-28 (watson Laboratories) treatment, the subject experienced various side effects, including:
  • Angiosarcoma
  • Hepatic Failure
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Levora 0.15/30-28 (watson Laboratories).

1 of 2 



Top 10 Levora Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Levora Side Effects

    Did You Have a Levora Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Levora for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Levora Safety Alerts, Active Ingredients, Usage Information

    NDC42254-260
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameLevora
    NameLevonorgestrel and Ethinyl Estradiol
    Dosage FormKIT
    Route
    On market since20020410
    LabelerRebel Distributors Corp
    Active Ingredient(s)
    Strength(s)
    Unit(s)
    Pharma Class

    Levora Dosage, Warnings, Usage.

    Side Effects reported to FDA: 37

    Levora safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 10

    Latest Levora clinical trials